A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

Recent news on Zyprexa


Counterfeit Zyprexa recalled  -  25 May 2007
Healthcare Republic (press release),The MHRA has issued a class 1 drug alert to recall three batches of counterfeit Zyprexa (olanzapine) 10mg found in a legitimate supply chain.

[url=http://nestorbrennan.007ihost.com/zyprexa-settlement.htm ...  -  25 May 2007
Female Soccer (subscription),If you would like to use any of the content on this website, you may do so, however, you MUST include the words: 'Information from www.femalesoccer.net'

APA: Metabolic Risks Ignored in Choice of Atypical Antipsychotics  -  25 May 2007
MedPage Today,...antipsychotic agent, either olanzapine (Zyprexa), risperidone (Risperdal), quetiapine (Seroquel), ziprasidone (Geodon) or aripiprazole (Abilify).

Utah Latest state to sue Eli Lilly in developing "Viva Zyprexa ...  -  May 22, 2007
World ForumSide effects to Zyprexa can include high blood sugar levels, acute weight gain and pancreatitis, according to the lawsuit.

Utah AG makes Zyprexa Eight in latest Big Pharma lawsuit pile-on  -  May 18, 2007
Legal News Line,Shurtleff filed suit Thursday against Lilly, claiming the company misled the state with a marketing blitz that promoted Zyprexa's utility for unapproved

Utah sues Lilly over Zyprexa  -  May 18, 2007
Indianapolis Star,SALT LAKE CITY -- Utah became the latest state to file a lawsuit against drug maker Eli Lilly and Co. over the anti-psychotic drug Zyprexa, alleging that

State of Utah sues Zyprexa maker  -  May 18, 2007
Salt Lake Tribune,Posted: 6:48 AM- SALT LAKE CITY -- Utah filed a lawsuit against the pharmaceutical company that makes the antipsychotic drug Zyprexa, alleging the state was

State of Utah Sues Zyprexa Maker  -  May 18, 2007
KSL-TV,Eli Lilly makes billions on diabetes treatment and also gets $4.2 billion a year in sales of their biggest cash cow Zyprexa which has been scandalized as

Utah Sues Zyprexa Maker Eli Lilly  -  May 17, 2007
Forbes,Utah filed a lawsuit Thursday against the pharmaceutical company that makes the antipsychotic drug Zyprexa, alleging the state was misled about risks to

New world, new dangers  -  May 22, 2007
Med Ad News (subscription),Lilly’s troubles stemming from a series of leaked documents about Zyprexa offer a cautionary tale to pharmaceutical executives about the perils of a digital

Akzo drug effective on manic episodes in trial  -  May 21, 2007
CNNMoney.comAfter two days of treatment, both asenapine and Zyprexa provided significantly greater reductions in mania scores than placebo.

Lilly's Worst Zyprexa Nightmare Comes True  -  May 7, 2007
Lawyers and Settlements,Washington, DC: Eli Lilly is not all that worried about personal injury lawsuits related to Zyprexa because the company has enough money to pay the

Akzo Nobel's Asenapine effective for bipolar I disorder in Phase ...  -  May 22, 2007
MarketWatchShe cautioned that "this is a very brief study, as it only compares Asenapine to Zyprexa, and isn'ta complete phase III trial."

FDA Looking At Zyprexa Data  -  Apr 25, 2007
Post ChronicleThe US Food and Drug Administration is reviewing documents provided by the maker of the antipsychotic drug Zyprexa. Eli Lilly & Company didn't give health

FDA looking at Zyprexa data  -  Apr 25, 2007
Monsters and Critics.com,Eli Lilly & Company didn`t give health regulators a February 2000 document that showed patients taking Zyprexa in clinical trials were 3 1/2 times as likely

Hopefully, This Will Work Better Than Zyprexa  -  Apr 29, 2007
ScienceBlogsDid you hear that Eli Lilly, the company that was caught in a big kerfuffle over Zyprexa (Olanzapine), recently released an antidepressant for dogs?

Questions Over Zyprexa Clinical Trial Data Underscore Need for ...  -  Apr 25, 2007
PharmaLive.com (press release),WASHINGTON, April 25, 2007 /PRNewswire-USNewswire/ -- Today's news that the Food and Drug Administration is examining whether the maker of Zyprexa failed to

Questions Over Zyprexa Clinical Trial Data Underscore Need for ...  -  Apr 25, 2007
PR-Inside.com (Pressemitteilung),WASHINGTON, April 25 /PRNewswire-USNewswire/ -- Today's news that the Food and Drug Administration is examining whether the maker of Zyprexa failed to

Questions Over Zyprexa Clinical Trial Data Underscore Need for ...  -  Apr 25, 2007
PR Newswire (press release),The New York Times reported today that the FDA has questions about an Eli Lilly & Co. document from February 2000 that found patients taking Zyprexa in a

FDA Probing Data on Antipsychotic Drug Zyprexa  -  Apr 25, 2007
Therapeutics Daily (subscription) (press release),The US Food and Drug Administration is investigating whether Eli Lilly & Company provided accurate data about the safety of the antipsychotic drug Zyprexa,

APA: Investigational Drug Comparable to Olanzapine for Bipolar Mania  -  May 22, 2007
MedPage Today,...in the acute manic phase responded as well to the investigational agent asenapine as they did to olanzapine (Zyprexa), reported investigators here.

Utah sues drug maker on behalf of Medicaid patients  -  May 19, 2007
Salt Lake Tribune,Some 1500 Utah adults with insurance coverage through Medicaid have developed diabetes because they took the antipsychotic drug Zyprexa, Utah's attorney

Big Headache for Big Pharma  -  May 15, 2007
Novopress North America,Just as Lilly’s legal muscle was lax during Christmas holidays, one of the expert witnesses in the Zyprexa litigation contacted human rights attorney Jim

State often ends probes without all the evidence  -  May 5, 2007
Atlanta Journal Constitution (subscription),Even if he needed Zyprexa, Barton said, his dosage was potentially lethal for a person his age, especially one with dementia. Zyprexa is thought to increase

Health Highlights: April 25, 2007  -  Apr 25, 2007
Washington Post,The US Food and Drug Administration is investigating whether Eli Lilly & Company provided accurate data about the safety of the antipsychotic drug Zyprexa

NYT Analysis Looks At Psychiatrists Who Receive Payments From Drug ...  -  May 14, 2007
Medical News Today (press release),Drugs in the best-selling class of antipsychotics -- which includes Risperdal, Seroquel, Zyprexa, Abilify and Geodon -- are being prescribed to more than

Eli Lilly says FDA has all Zyprexa data  -  26 Apr 2007
ReutersOn Wednesday, the New York Times reported the FDA is examining whether Lilly gave it accurate data about the side effects of Zyprexa.

Eli Lilly's problems go beyond quarterly results  -  26 Apr 2007
Blogging StocksLilly still faces more than 1000 lawsuits related to use of its antipsychotic drug Zyprexa. The legal bill for this drug has already surpassed the $1

USPSYCH: New Definitions on Tap for Mixed Manias  -  26 Apr 2007
Psychiatric Times,...risperidone (Risperdal) or ziprasidone (Geodon) as initial treatment with olanzapine (Zyprexa) and clozapine (Clozaril) as alternate choices.

US PSYCH: Vigilance Still Necessary for Atypical Antipsychotics  -  26 Apr 2007
Psychiatric Times,Clozapine (Clozaril) and olanzapine (Zyprexa) have the highest receptor affinity with quetiapine (Seroquel) and risperidone (Risperdal) in the middle and

Protective Orders May Offer Minimal 'Protection'  -  Apr 24, 2007
Law.com (subscription),This article discusses a recent decision by Judge Jack Weinstein in the Zyprexa Litigation, a multidistrict litigation pending in the US District Court for

How To Get Zyprexa Lawsuit Funding Litigation Funding Posted By :  -  Apr 18, 2007
Business Portal 24 (press release),A risk free source of legal finance is now available for plaintiffs involved in Zyprexa class action lawsuit. It is called Lawsuit funding or often referred

Lilly says continued Zyprexa sales growth unlikely  -  Apr 16, 2007
ReutersN: Quote, Profile , Research) said on Monday that strong first-quarter sales growth for its Zyprexa schizophrenia drug was due largely to cutbacks in

Lilly says continued Zyprexa sales growth unlikely  -  Apr 16, 2007
Therapeutics Daily (subscription) (press release),NEW YORK (Reuters) - Eli Lilly and Co. said on Monday that strong first-quarter sales growth for its Zyprexa schizophrenia drug was due largely to cutbacks

No good drug for treating schizophrenia  -  Apr 23, 2007
The Brunei Times,They included Johnson & Johnson's risperidone, sold under the brand name Risperdal; olanzapine, made by Eli Lilly and Co under the brand name Zyprexa;

An Expert's Escapade, a Cautionary Tale  -  Apr 24, 2007
Business Portal 24 (press release),A federal judge's 78-page order enjoining an expert involved in Zyprexa mass-tort litigation from releasing documents serves as a cautionary tale for any

Analysis: Former drug rep reveals tactics  -  Apr 23, 2007
United Press International..."I would be pushing for some sort of restriction to access," Ahari, who has testified about Lilly's tactics for promoting Zyprexa, told UPI.

Eli Lilly Shareholders Join Zyprexa  -  Apr 10, 2007
Tehachapi News,...(A) Year 1996 FDA approves Zyprexa for schizophrenia (at first,later on for mania) which is only about 1% and 3% of the population to lessen delusional

Senator to Lilly: Turn over Zyprexa files  -  Apr 5, 2007
Indianapolis Star,Zyprexa is at the center of lawsuits by patients, states and shareholders over whether Lilly knew Zyprexa could trigger diabetes in some people and whether

Shareholder Class Action Filed Against Eli Lilly concerning Zyprexa  -  Apr 3, 2007
YubaNet,Sales of Zyprexa grew from $3.69 billion to $4.42 billion between 2002 and 2004, and Lilly's stock price increased from $43.75 per share to $76.95 per share

Lilly faces Zyprexa suit from investors  -  Apr 4, 2007
Indianapolis Star,First it was patients suing Eli Lilly and Co. claiming that its blockbuster drug Zyprexa can trigger diabetes in some people.

Zyprexa now focus of shareholder suit  -  Apr 3, 2007
Indianapolis Star,The complaint alleges Lilly knew of links between Zyprexa and extreme weight gain and diabetes and that it marketed Zyprexa for uses that were not approved

Lilly shareholders sue over anti-psychotic drug Zyprexa  -  Apr 3, 2007
Canada.com,INDIANAPOLIS (AP) - Shareholders have become the latest plaintiffs to sue Eli Lilly and Co. over its top-selling drug, the anti-psychotic Zyprexa.

Court case to reclaim confidential data  -  Apr 20, 2007
Nature.com (subscription),Lilly's best-earning drug is Zyprexa, a treatment for schizophrenia that brings in more than US$4 billion a year. But over the past two years Lilly has paid

Lilly First-Quarter Profit Falls on Icos Purchase (Update3)  -  Apr 16, 2007
BloombergLilly faces growing competition for its diabetes drugs and the schizophrenia treatment Zyprexa, its top-selling medication. Demand for Zyprexa waned after

Lilly First-Quarter Profit Falls on Icos Purchase (Update4)  -  Apr 16, 2007
BloombergLilly said sales jumped 10 percent for the schizophrenia drug Zyprexa, its top seller, and 89 percent for the Cymbalta antidepressant.

Harwood Feffer LLP Announces Securities Class Action Suit Against ...  -  Apr 11, 2007
Primenewswire (press release),As a result of defendants' fraudulent business practices, sales of Zyprexa grew from $3.69 billion to $4.42 billion between 2002 and 2004, and the value of

Lilly First-Quarter Profit Falls on Icos Purchase (Update1)  -  Apr 16, 2007
BloombergLilly faces growing competition for its diabetes drugs and the schizophrenia drug Zyprexa, its top-selling medication. Demand for Zyprexa waned after some

Security Class Action Lawsuit - Eli Lilly & Company  -  Apr 11, 2007
Lawfuel (press release),Throughout the Class Period, however, the defendants had access to internal information concerning a link between the use of Zyprexa and the adverse

Lilly beats Street on Cymbalta demand  -  Apr 16, 2007
Canada.com,Cancer treatments Gemzar and Alimta, schizophrenia drug Zyprexa and impotence treatment Cialis all showed sales gains.

Analysis: Mixed views on Lilly's strong Q1  -  Apr 16, 2007
United Press InternationalDespite his enthusiasm, Schott said he wanted more clarity on the outlook and sustainability of Zyprexa, Cymbalta, Alimta and Humalog.

Eli Lilly 1Q Profit Tumbles on Charges  -  Apr 16, 2007
WTOP,Lilly, whose prescription drugs include Cialis, Cymbalta and Zyprexa, said net income totaled $508.7 million, or 47 cents per share in the first three

Schatz Nobel Izard, PC Announces Class Action Lawsuit Against Eli ...  -  Apr 9, 2007
Primenewswire (press release),The Complaint alleges that Lilly and certain of its officers and directors violated Federal Securities laws by making misleading statements about Zyprexa,

Eli Lilly upbeat on outlook  -  Apr 16, 2007
MSNBCStrong sales in key faster-growing new drugs and Lilly's attempts to boost sales of Zyprexa were also behind the upbeat forecast.

Eli Lilly's quarterly net slips; year view boosted  -  Apr 16, 2007
MarketWatchSales of Zyprexa, Eli Lilly's top-selling product, were $1.11 billion, up 10% from a year earlier. US sales rose 6% to $523.3 million, primarily due to

Eli Lilly's quarterly net slips; year view boosted  -  Apr 16, 2007
MarketWatchSales of Zyprexa, Eli Lilly's top-selling product, were $1.11 billion, up 10% from a year earlier, as US sales rose 6% to $523.3 million.

Eli Lilly's Profit Declines 39%  -  Apr 16, 2007
Wall Street Journal (subscription),Sales of Zyprexa, Lilly's top-selling product, rose 10% to $1.11 billion from a year earlier. US sales rose 6% to $523.3 million.

Eli Lilly first-quarter net down amid charges; sales up 14%  -  Apr 16, 2007
MarketWatchZyprexa was linked with substantial weight gain in some patients and is suspected of triggering diabetes in others. The company settled 18000 cases related

Lerach Coughlin Stoia Geller Rudman & Robbins LLP Files Class ...  -  Apr 6, 2007
PharmaLive.com (press release),Lilly produces and markets Zyprexa, a drug treatment for schizophrenia, among other things. Zyprexa is by far Lilly's largest-selling drug, with sales of

Lerach Coughlin Stoia Geller Rudman & Robbins LLP Files Class ...  -  Apr 5, 2007
Business Wire (press release),Lilly produces and markets Zyprexa, a drug treatment for schizophrenia, among other things. Zyprexa is by far Lilly’s largest-selling drug, with sales of

The Hardest Trade to Make  -  Apr 20, 2007
TheStreet.com (subscription),You'd have to be on crack, peyote, Vicodin, and Zyprexa all at once to be that nutty. There's an old saw on Wall Street about how the hardest trade to make

Patients Diagnosed Schizophrenic and Bipolar To Boost Seroquel Sales  -  Apr 11, 2007
Lawyers and Settlements,The other drugs in this class include Eli Lilly's Zyprexa, Bristol-Myers Squibb's Abilify, Johnson & Johnson's Risperdal, and Pfizer's Geodon.

/CORRECTION -- Grant & Eisenhofer PA/  -  Apr 5, 2007
Drug Newswire (press release),The Complaint alleges that for over a decade, Eli Lilly knew of links between Zyprexa and extreme weight gain and diabetes. In addition, during the Class

Eli Lilly Profits Down  -  Apr 16, 2007
Forbes,Top-seller Zyprexa, an anti-psychotic, saw sales climb 10 percent to $1.11 billion, marking the fourth straight quarter that sales have increased when

Lilly profit falls 39 percent  -  Apr 16, 2007
CNNMoney.comZyprexa revenue rose 10 percent during the quarter to $1.11 billion. Demand for the drug waned in the United States amid concerns about its tendency to


This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional